Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Sources Sought opportunity from Department Of Health And Human Services was posted on August 24, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Py-GC/MS for Micro- and Nanoplastic Analysis

Closed
75N992-26-SS-106Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 334516
New
SLED
NDSU - Dynamic Mechanical Analyzer
Solicitation # SRC000482
North Dakota State University (NDSU) is soliciting bids under solicitation SRC000482 for a Dynamic Mechanical Analyzer (DMA) system to support polymer testing research on electrically responsive surface textures for autonomous platforms. The required system must support dynamic mechanical analysis in bending, tension, and compression modes, featuring a frequency range of 2 x 10-8 Hz to 200 Hz, a temperature range of -170 C to +600 C, and a normal force sensor range of 0.001 N to 50 N. Optional rotational or torsional torque capabilities may be offered separately and will not be included in the base bid evaluation. The equipment is to be delivered FOB Destination to R1A Laboratories in Fargo, North Dakota, where final acceptance will be contingent upon successful installation, functional demonstration, and the completion of required training. The contract will be awarded to the lowest responsive and responsible bidder who meets all mandatory technical specifications. Bidders must submit their responses through the NDBuys portal by November 4, 2026, including a completed Cost Proposal Form and a Technical Compliance Form. The base bid must be comprehensive, covering all hardware, software, delivery, installation, and warranty costs. All communications must be directed exclusively to the Procurement Officer, Casie Ewalt. Awardees must comply with North Dakota open records laws and non-discrimination policies, and they must certify that they are not proposed for federal debarment or suspension.

POSTED

about 6 hours ago

DEADLINE

in 8 days
NAICS: 334516
New
Federal
6632--FY27 Microbial Incubation ID and Susceptibility CPT
Solicitation # 36C24827Q0029
The Department of Veterans Affairs is conducting market research through a Sources Sought Notice to identify qualified vendors capable of providing a comprehensive Microbial Incubation, Identification (ID), and Antimicrobial Susceptibility Testing (AST) system for the James A. Haley Veterans Hospital in Tampa, Florida. The requirement includes the delivery and installation of two redundant analyzers—one large capacity and one medium capacity—along with incubators, middleware, and hardware and software for up to ten workstations. Technical specifications require a bi-directional, bar-coded computer interface compatible with VA laboratory systems and specific sensitivity and resolution standards for MALDI TOF systems. The scope also encompasses a continuous supply of reagents, calibrators, and consumables, which must have a minimum shelf life of six months upon delivery. Interested parties must submit a brief capability statement by November 10, 2026, including their SAM Unique Entity ID, socioeconomic status, and evidence of their ability to meet the functional requirements under NAICS code 334516. Respondents should identify available contract vehicles, such as GSA FSS or NASA SEWP, and provide estimated timelines for delivery, validation, and software implementation. The government will evaluate submissions based on technical specifications, manufacturer reputation, and the ability to provide a tiered pricing structure for cost-per-test (CPT) models. This notice is for planning purposes only and does not constitute a formal solicitation; however, it establishes strict requirements for data security, NARA-compliant data destruction, and mandatory personnel training for any future awarded contractor.
248-NETWORK Contract Office 8 (36C248)

POSTED

about 15 hours ago

DEADLINE

in 14 days

AI Contract Overview

Show more

The Advanced Research Projects Agency for Health (ARPA-H) Health Science Futures Office is issuing a Sources Sought notice, solicitation number 75N992-26-SS-106, to identify industry capabilities for gold-standard Pyrolysis-gas chromatography/mass spectrometry (Py-GC/MS) analysis of micro- and nanoplastics (MNPs) in biological samples, including blood, urine, and tissue. The objective is to establish a standardized measurement tool within nine months of contract start and provide analytical services for up to 60 months. The required analysis must cover specific polymers such as PE, PP, PVC, PET, Ny-6, PS, PMMA, PU, and SBR, with a desired limit of detection between 10 and 20 ng and a limit of quantitation between 30 and 80 ng. To ensure quality and minimize contamination, providers must have access to at least an ISO-7 clean room or workstation. This notice is for market research purposes and is not a formal solicitation. Interested parties must submit unclassified responses by September 8, 2026, including technical descriptions, a rough annual cost estimate, and evidence of at least two relevant contracts from the last 36 months. Submissions are limited to six pages and must include administrative data such as Cage Code, UEI, and business size relative to NAICS codes 334516, 325211, or 541713. Responses should be sent electronically to the designated points of contact at ARPA-H.

General Info

ARPA-H seeks vendors for Py-GC/MS analysis of microplastics in biological samples by September 2026.

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Place of Performance

77416, DC, USA

Set-Aside

NONE

Documents

1

Sources Sought 75N992-26-SS-106 for Py-GC/MS Micro- and Nanoplastic Analysis

PDF, High priority: read this firstsources-sought
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
Contacts1 person available
OfficeWashington, DC, 20005, USA
Office AddressWashington, DC, 20005, USA
Contacts
The STOMP Team

Full Description

Show more

The intent of this Sources Sought notice is to gauge industry interest, capabilities, and relevant experience to support Advanced Research Projects Agency for Health (ARPA-H) Health Science Futures Office (HSF) by providing gold-standard Pyrolysis-gas chromatography/mass spectrometry (Py-GC/MS) analysis of micro- and nanoplastics (MNPs) in biological samples, such as blood, urine and tissue.


Specifically, ARPA-H is looking for the capability to perform Py-GC/MS analysis of MNPs in biological samples.


See attached for sources sought request and response instructions. 

More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Same awarding agency

NAICS: 541714
New
Federal
ARPA-H Emerging Health Innovators (EHI) Initiative
Solicitation # ARPA-H-SOL-26-150
The Advanced Research Projects Agency for Health (ARPA-H) Emerging Health Innovators (EHI) initiative, solicitation ARPA-H-SOL-26-150, seeks to identify and engage early-career investigators to develop cutting-edge biomedical, health, and community-engaged research. This opportunity is open to researchers from academic, nonprofit, and industry organizations, provided the Principal Investigator is within eight years of completing their first terminal degree. The initiative covers 16 specific topic areas, including AI in life sciences, brain stimulation, and human tissue platforms. Awards are issued as Other Transaction (OT) agreements, which are not subject to the Federal Acquisition Regulation (FAR). The selection process is a two-step submission involving an initial anonymized Solution Summary and a subsequent Full Proposal for selected candidates. Successful awards have a total value not to exceed 1,050,000 dollars over a three-year period, consisting of a 24-month base period capped at 700,000 dollars and an optional 12-month Director's Award period capped at 350,000 dollars. Payments are structured as fixed payments triggered by the completion of 12 discrete, measurable milestones. Full proposals are evaluated based on technical merit, innovativeness, feasibility, alignment with the ARPA-H mission to accelerate health outcomes, and price reasonableness. Administrative requirements include mandatory registration in SAM.gov and the use of the ARPA-H Solutions site for all submissions. Proposers must adhere to strict formatting templates for technical and management proposals, milestone schedules, and national policy requirements, including disclosures regarding organizational conflicts of interest and research security. Performance is monitored through a formal inspection and acceptance process where the government reviews deliverables within 14 calendar days. The tentative award start date is June 30, 2027, with full proposals due by February 10, 2027.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

6 days ago

DEADLINE

in 4 months
View Details
NAICS: 541715
New
Federal
Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Innovative Solutions Opening
Solicitation # ARPA-H-SOL-26-160
The Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and Supplies (FASTPASS) program, under solicitation ARPA-H-SOL-26-160, is an initiative by the Advanced Research Projects Agency for Health (ARPA-H) to develop a near real-time, non-destructive, AI-enabled screening system. The goal is to identify contamination, adulteration, and quality defects in pharmaceutical products through their packaging at ports of entry and other supply-chain nodes using multi-modal sensing and data fusion. This 54-month program is structured into three 18-month phases, culminating in a fieldable platform with validated training materials and integrated documentation capabilities. This procurement is conducted as a multiple-award Other Transaction (OT) Agreement rather than a standard federal contract, meaning it is governed by specific OT articles instead of the Federal Acquisition Regulation. Awards are based on the most advantageous proposals, with primary evaluation factors including innovation, soundness, execution planning, risk management, and team expertise. Payments are fixed and triggered by the successful completion of milestones, managed through the Payment Management System. Proposers must be registered in SAM.gov and provide detailed technical and cost proposals, including a milestone payment schedule and research security disclosures. Amendment 01 specifically updated the cost proposal narrative model and workbook to correct typographical errors and rename appendices.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

7 days ago

DEADLINE

in 14 days
View Details
NAICS: 541714
Federal
Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Solicitation # ARPA-H-SOL-26-164
The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals for the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program under solicitation ARPA-H-SOL-26-164. This five-year initiative aims to create a reusable blueprint for future adaptive seamless platform trials through the integration of three technical areas: a Phaseless Design Engine, Continuous Inference, and Agentic Operations. The program is divided into two stages, with Stage I focusing on capability buildout, FDA engagement, and the onboarding of at least three intervention arms over 24 months, followed by a 36-month Stage II dedicated to validation and deployment. A critical go/no-go milestone is obtaining FDA authorization for the platform Master Protocol IND and at least one investigational arm by the end of Stage I. The government intends to make multiple awards via Other Transaction Agreements to proposers offering the most advantageous solutions based on innovation, feasibility, and technical merit at reasonable prices. Eligible entities must possess a Unique Entity Identifier and active SAM registration. Proposals are submitted in a phased approach, beginning with a Solution Summary and potentially progressing to a Solution Pitch package. Performance will be measured by the successful integration of the three technical areas and the achievement of specific program metrics. All work must adhere to ICH E6(R3) Good Clinical Practice and strict regulatory standards to ensure inspection readiness and participant safety.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

28 days ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
Federal
UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening (ISO)
Solicitation # ARPA-H-SOL-26-162
The Advanced Research Projects Agency for Health (ARPA-H) is seeking innovative solutions through the UNifying Imaging with QUantum Entanglement (UNIQUE) program, solicitation number ARPA-H-SOL-26-162. This 18-month, two-phase initiative aims to develop a new biomedical imaging paradigm by integrating anatomical, functional, and molecular data using quantum-derived observables and entangled 511 keV photon pairs. The scope is divided into two technical areas: the Imaging Core, which focuses on physical systems for generating and measuring quantum observables, and the Computational Foundation, which focuses on AI-driven reconstruction and multimodal data fusion. ARPA-H anticipates awarding multiple Other Transaction Agreements to eligible universities, non-profit organizations, and businesses. The submission process is two-staged, requiring Solution Summaries by late October 2026 and Full Proposals by December 15, 2026. Full proposals must consist of three volumes covering technical and management plans, cost proposals, and administrative requirements. Evaluation is based on technical innovation and feasibility, proposer expertise, potential to transform biomedicine, and cost reasonableness. Notably, for-profit organizations that are not small businesses under NAICS 541714 are required to provide a meaningful cost share. All participants must adhere to strict HHS regulations regarding human stem cell research and prohibitions on dangerous gain-of-function research and funding for foreign entities in countries of concern.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS